Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/2103 : 27Business WireApplications Software Technology akquiriert Symatrix zur Beschleunigung der globalen Expansion mit Oracle Cloud Services
2024/05/2103 : 25Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:BMOBank of Montreal
2024/05/2103 : 25PR Newswire (US)ECI Connect Customer Conference 2024: SMBs, Executives, Industry Experts Come Together to Discuss Software Optimization, Business Management, AI and More
2024/05/2103 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GLGlobe Life Inc
2024/05/2103 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LEALear Corp
2024/05/2103 : 22Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BNSBank Nova Scotia Halifax
2024/05/2103 : 22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNEYCN Energy Group Inc
2024/05/2103 : 21Alliance NewsAlliance NewsJersey Electricity says revenue lifted by strong showing by Energy armLSE:JELJersey Electricity Plc
2024/05/2103 : 21Alliance NewsAlliance NewsJersey Electricity says revenue lifted by strong showing by Energy armLSE:JELJersey Electricity Plc
2024/05/2103 : 21Alliance NewsAlliance NewsJersey Electricity says revenue lifted by strong showing by Energy armLSE:JELJersey Electricity Plc
2024/05/2103 : 21PR Newswire (US)LandSouth Breaks Ground on Tuscany Village
2024/05/2103 : 20Business WireLenovo Supercharges Next Gen Copilot+ PCs with Latest Yoga Slim 7x and ThinkPad T14s Gen 6
2024/05/2103 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ARWArrow Electronics Inc
2024/05/2103 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GIFIGulf Island Fabrication Inc
2024/05/2103 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NLSCNam Liong Sky Cosmos Inc (PK)
2024/05/2103 : 16PR Newswire (US)Lennox to increase quarterly dividendNYSE:LIILennox International Inc
2024/05/2103 : 15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:LEALear Corp
2024/05/2103 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:YUMYum Brands Inc
2024/05/2103 : 15GlobeNewswire Inc.Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJMTG:SNWSanofi
2024/05/2103 : 15GlobeNewswire Inc.Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJMBIT:SANFSanofi
2024/05/2103 : 15GlobeNewswire Inc.Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCOBIT:SANFSanofi
2024/05/2103 : 15GlobeNewswire Inc.Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCOTG:SNWSanofi
2024/05/2103 : 15GlobeNewswire Inc.Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCOEU:SANSanofi
2024/05/2103 : 15GlobeNewswire Inc.Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCOBIT:1SANSanofi
2024/05/2103 : 15GlobeNewswire Inc.Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJMEU:SANSanofi
2024/05/2103 : 15GlobeNewswire Inc.Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJMEU:SANSanofi
2024/05/2103 : 15GlobeNewswire Inc.Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJMBIT:1SANSanofi
2024/05/2103 : 15GlobeNewswire Inc.Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of MedicineNASDAQ:REGNRegeneron Pharmaceuticals Inc
2024/05/2103 : 15PR Newswire (US)The Inner Circle Acknowledges, Brian J. Hudec, DMD as a Pinnacle Lifetime Member
2024/05/2103 : 15PR Newswire (US)New Video from Madison Liquidators Features the Best-Selling L-Shaped Desk

最近閲覧した銘柄

Delayed Upgrade Clock